Cite
MLA Citation
E. Lee et al.. “PB2138: VITALIZE TRIAL: A PHASE 2B, OPEN-LABEL, MULTICENTER, RANDOMIZED PARALLEL-GROUP, TWO-STAGE, STUDY OF MAVEROPEPIMUT-S, PEMBROLIZUMAB, WITH OR WITHOUT INTERMITTENT LOW-DOSE CYCLOPHOSPHAMIDE, IN R/R DLBLC.” HemaSphere, vol. 6, n.d., pp. 2009–2010. http://access.bl.uk/ark:/81055/vdc_100159756479.0x000008